8 Questions on Managing Lung Cancer

Collaboration Fosters Treatment Advancements for Young Lymphoma Populations

The VIOLETTE trial, which used OBT-fusion technology for patients with focal ablation of the prostate by microwave needles, released interim results.

A leader from the adolescent and young adult lymphoma space discusses how collaboration between adult and pediatric oncologists has transformed the field.

Andrew M. Evens, DO, MS

November 18th 2024

FDA Updates Fludarabine Phosphate Labeling in Chronic Lymphocytic Leukemia

A leader from the adolescent and young adult lymphoma space discusses how collaboration between adult and pediatric oncologists has transformed the field.

The updated labeling also includes new information on the recommended dosage of fludarabine phosphate when given with cyclophosphamide and rituximab.

Russ Conroy

Educating Patients and Clinicians on End-of-Life Care and Discussions

The updated labeling also includes new information on the recommended dosage of fludarabine phosphate when given with cyclophosphamide and rituximab.

Kelley A. Rone, DNP, RN, AGNP-c

November 11th 2024

Multiple Myeloma Experts Face Off on Sequencing Therapy Options

Kelley A. Rone, DNP, RN, AGNP-c, provides perspective on approaching end-of-life conversations with patients with GI cancers.

ONCOLOGY Staff

FDA OKs Zanidatamab Injection for Metastatic HER2+ Biliary Tract Cancer

Experts in multiple myeloma gathered to debate current treatment options in the space during a recent Face Off.

Results from the HERIZON-BTC-01 trial led to the approval of zanidatamab for patients with metastatic HER2-positive biliary tract cancer.

Ariana Pelosci

VIOLETTE Trial Shows Precise Planning in Prostate Cancer Microwave Ablation

Results from the HERIZON-BTC-01 trial led to the approval of zanidatamab for patients with metastatic HER2-positive biliary tract cancer.

Related Content

Tim Cortese

November 22nd 2024

Collaboration Fosters Treatment Advancements for Young Lymphoma Populations

The VIOLETTE trial, which used OBT-fusion technology for patients with focal ablation of the prostate by microwave needles, released interim results.

Andrew M. Evens, DO, MS

November 18th 2024

FDA Updates Fludarabine Phosphate Labeling in Chronic Lymphocytic Leukemia

A leader from the adolescent and young adult lymphoma space discusses how collaboration between adult and pediatric oncologists has transformed the field.

Russ Conroy

Educating Patients and Clinicians on End-of-Life Care and Discussions

The updated labeling also includes new information on the recommended dosage of fludarabine phosphate when given with cyclophosphamide and rituximab.

Kelley A. Rone, DNP, RN, AGNP-c

November 11th 2024

Multiple Myeloma Experts Face Off on Sequencing Therapy Options

Kelley A. Rone, DNP, RN, AGNP-c, provides perspective on approaching end-of-life conversations with patients with GI cancers.

ONCOLOGY Staff

FDA OKs Zanidatamab Injection for Metastatic HER2+ Biliary Tract Cancer

Experts in multiple myeloma gathered to debate current treatment options in the space during a recent Face Off.

Ariana Pelosci